InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: nutsyprofessor post# 23939

Tuesday, 01/14/2014 4:21:14 PM

Tuesday, January 14, 2014 4:21:14 PM

Post# of 425917
"the FDA has rescinded the ANCHOR study special protocol assessment agreement because the FDA has determined that a substantial scientific issue essential to determining the effectiveness of Vascepa in the studied population was identified after testing began"

There was no, none, zilch, zero....studies that determined a substantial scientific issue relating to mineral oil. Unless I am mistaken, at which point you will provide a link to show one does. Otherwise, issue of mineral oil is moot.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News